Table 3.
Characteristics of the procedure in patients with and without PPI after TAVI
| PPI (n = 135) | Non-PPI (n = 535) | p value | |
|---|---|---|---|
| Anesthesia | 0.769 | ||
| Sedation | 8.9% (12) | 9.7% (52) | |
| General | 91.1% (123) | 90.3% (483) | |
| Vascular access | 0.537 | ||
| Transfemoral or iliac | 97.0% (131) | 95.9% (513) | |
| Others | 3.0% (4) | 4.1% (12) | |
| Successful device implantation | 88.9% (120) | 89.2% (417) | 0.928 |
| Poor overlapping | 3.7% (5) | 4.5% (24) | 0.690 |
| Prosthesis migration or embolization | 3.0% (4) | 2.6% (14) | 0.824* |
| Need for a second prosthesis | 3.7% (5) | 4.1% (22) | 0.829 |
| Transesophageal echocardiography | 75.6% (102) | 82.2% (440) | 0.077 |
| Pre-dilation | 54.1% (73) | 48.2% (258) | 0.224 |
| Bioprosthesis type | < 0,001 | ||
| CoreValve | 88.1% (119) | 70.8% (379) | |
| SapienXT | 11.9% (16) | 29.2% (156) | |
| Post-dilation | 40.7% (55) | 37.0% (198) | 0.424 |
(*)
Likelihood ratio; Student t test for continuous variables; chi-square test for categorical variables.